Skip to content

Author

A. Wali

We have 6 of 112 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Diabesity: an old term, a modern challenge — multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes

Evidence for approved and investigational oral incretin therapies, dual and triple receptor agonists, amylin-based strategies, established antidiabetic drugs, and adjunctive approaches targeting body composition are summarized.

Karolina Hoffmann, Weronika Pucek, Wiktoria Skrzypek et al. · 0 citations
Sep 2026

A comprehensive evaluation of Saussurea costus root extracts: Antioxidant, cytotoxic, wound-healing, anti-inflammatory, and antimicrobial activities

Infectious diseases, compounded by escalating antimicrobial resistance (AMR), remain a global health challenge. Saussurea costus ( Saussurea lappa ) is an endangered Himalayan medicinal plant with diverse bioactive compounds. This study evaluated the phytochemical profile and biological activities of its methanol...

Alyaa Alramah, Maaida Sheikh, Rigashy Raghavan et al. · 0 citations
Review Open access Sep 2026

Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes

Osteoporosis is a major skeletal disorder. Increasing evidence suggests that gut microbiota-derived mechanisms may contribute to bone remodeling. The biological rationale for a gut–bone axis is well supported, but the clinical relevance of microbiome-targeted interventions remains uncertain. In this narrative review, w...

Sorina Ispas, V. Maggio, A. Wali et al. · 0 citations
Review Open access Jan 2026

Microbiome‐Driven Mechanisms in Breast Cancer: Emerging Evidence From Gut Microbial Signatures to Therapeutic Response

Current preclinical and clinical evidence describing the gut–breast cancer axis and its mechanistic and translational relevance is summarized and current advances in microbiome‐targeted interventions including probiotics, dietary modulation, postbiotics, and fecal microbiota transplantation are discussed.

A. Wali, Sirajunisa Talath, I. Rangraze et al. · 0 citations
Review Open access Sep 2026

Bioinspired and Biomimetic Nanocarriers: Advances in Exosomes and Cell-Membrane-Coated Systems for Therapeutic Applications

Abstract The translation of nanomedicine from bench to bedside has been thwarted by the limitations of conventional synthetic nanoparticles including rapid mononuclear phagocyte system (MPS) clearance, lack of target specificity, immunogenicity and poor intracellular delivery. To overcome these limitations, bioinspired...

M. El-Tanani, S. A. Rabbani, A. Wali et al. · 0 citations
Review Open access Sep 2026

Pathological Complete Response to Nab-Paclitaxel–Containing Neoadjuvant Regimens in Early Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

Within nab-paclitaxel-containing neoadjuvant backbones, checkpoint-inhibitor addition was associated with higher pCR in randomized comparative evidence, and should not be interpreted as a cross-regimen comparison because of clinical and methodological heterogeneity.

R. A. Salama, M. El-Tanani, S. A. Rabbani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.